Pavika J Lyngsie1, Sandra Lopes1, Jens Olsen2. 1. Novo Nordisk Scandinavia AB, Arne Jacobsens Allé 17, DK-2300 København S, Denmark. 2. Incentive, Holte Stationsvej 14, DK-2840 Holte, Denmark.
Abstract
AIMS: The purpose of this study was to estimate the incidence and hospital costs associated with hypoglycemic episodes (HEs) requiring hospital admission or emergency room (ER) visits in Denmark. MATERIALS & METHODS: This study analyzed data from the National Patient Registry. Data on HE-related hospital admissions or ER visits occurring between 2008 and 2011 were collected and analyzed. RESULTS: There were 1906 hospital admissions and 803 ER visits in 2008 compared with 1646 hospital admissions and 547 ER visits in 2011, corresponding to a decrease in incidence from 10.6 to 7.1. The estimated annual total hospital costs ranged from €3.0 million in 2008 to €2.3 million in 2011. CONCLUSION: HEs represent a major burden for the Danish healthcare system.
AIMS: The purpose of this study was to estimate the incidence and hospital costs associated with hypoglycemic episodes (HEs) requiring hospital admission or emergency room (ER) visits in Denmark. MATERIALS & METHODS: This study analyzed data from the National Patient Registry. Data on HE-related hospital admissions or ER visits occurring between 2008 and 2011 were collected and analyzed. RESULTS: There were 1906 hospital admissions and 803 ER visits in 2008 compared with 1646 hospital admissions and 547 ER visits in 2011, corresponding to a decrease in incidence from 10.6 to 7.1. The estimated annual total hospital costs ranged from €3.0 million in 2008 to €2.3 million in 2011. CONCLUSION: HEs represent a major burden for the Danish healthcare system.
Entities:
Keywords:
burden of disease; diabetes; hospital costs; incidence; severe hypoglycemia
Authors: Saskia de Groot; Catherine F Enters-Weijnen; Petronella H Geelhoed-Duijvestijn; Tim A Kanters Journal: BMJ Open Date: 2018-03-25 Impact factor: 2.692